Treatment with interferon-beta (IFN-β) reduces the inflammatory response in immune cells from Sjögren’s syndrome patients, a study reports. The findings suggest that treatment with IFN-β may be a potential way of controlling inflammation in Sjögren’s patients. The study, “…
News
Yeast colonization in the oral cavity of patients with Sjogren’s syndrome follows a different pattern compared to healthy people, suggesting a reason why some patients respond better to commonly prescribed antifungal agents compared with others, a new study shows. The study, “Oral yeast colonization in patients with…
Oral Health of Primary Sjögren’s Patients Seen as Similar to That of Healthy Controls in Small Study
The oral health of patients with primary Sjögren’s syndrome is similar to that of patients with rheumatoid arthritis or healthy individuals, a small study suggests. The study, “Clinical periodontal status and inflammatory cytokines in primary sjogren syndrome and rheumatoid artritis,” was published in The Journal of Periodontology. Primary Sjögren’s…
As President Trump signed the recently passed Right to Try legislation into law in a White House ceremony, Jordan McLinn of Indianapolis tried twice to embrace him. The third time, 9-year-old Jordan finally got the hug he wanted — as well as a kiss on the forehead. The video of…
Use of big data machine learning to study autoimmune diseases is on the rise, but little focus has been devoted to primary Sjogren’s syndrome (pSS), a French study reports. The study, “Pathogenesis-based treatments in primary Sjogren’s syndrome using artificial intelligence and advanced machine learning techniques: a…
Finding treatments and potential cures for rare diseases is crucial, but so is the quality of patients’ lives — a rather nebulous term that means different things to different people. “Recently, there’s been much more of a focus on Quality of Life (QoL) issues, real-world evidence and patient-reported outcomes,” said…
LO2A eye drops significantly improve dry eye symptoms in Sjögren’s syndrome patients, according to a small Phase 2 clinical study performed in Hungary. The findings were presented at the Association for Research in Vision and Ophthalmology (ARVO) Annual Meeting, on May 2 in Honolulu, Hawaii, in the poster presentation “…
Patients with primary Sjögren’s syndrome and joint inflammation are significantly more likely to have severe or very severe dry eye, according to a multi-center study in Spain. The finding suggests a potential new strategy to identify signs of the disease that may lead to early treatment. The study, “Factors associated…
Researchers recently identified an autoantibody — an antibody produced against a person’s own tissue or molecule — significantly associated with the peripheral nerve damage common in Sjögren’s syndrome patients. This finding may help scientists understand the cause and development of peripheral nerve damage in this autoimmune disease, as well as…
The 2018 Walk for Sjögren’s in the greater Washington, D.C., area will take place Saturday, May 19 in Reston, Virginia, to raise awareness for Sjögren’s syndrome. Walk for Sjögren’s is a national event created by the Sjögren’s Syndrome Foundation to increase awareness and raise money to support…
Recent Posts
- Blood molecule may offer new way to detect and track Sjögren’s disease
- A closer look at Sjögren’s disease: How Johnson & Johnson is driving patient-informed research
- Childhood-onset Sjögren’s can cause lasting damage to organs: Study
- Salivary duct treatment eases dry mouth in Sjögren’s disease: Study
- 4 genes linked to inflammatory cell death very active in Sjögren’s
- AI can see what doctors miss to accurately diagnose Sjögren’s
- Worse fatigue tied to more pain in people with Sjögren’s, study finds
- Dazodalibep therapy now in Phase 3 testing for Sjögren’s disease
- Sjögren’s treatment ianalumab shows rapid disease relief in trials
- Sjögren’s patients on nipocalimab report less pain, dryness in trial